Lexington Partners has closed its latest secondary fund at $7 billion, making it the largest-ever secondaries offering, Dow Jones reported, citing people familiar with the situation. The fund includes separate accounts – including one held by China Investment Corporation (CIC) – that invest alongside the main fund on a pro rata basis.
Lexington Capital Partners VII LP, said to be more than 80% larger than its predecessor, officially came to market in 2010. It was reported that the fund had exceeded its $5 billion target by January of...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.